These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3201096)

  • 21. [Liver function in porphyria cutanea tarda. Experiences with 32 patients].
    Pietschmann H; Raab W; Hartl O
    Wien Z Inn Med; 1966 Sep; 47(9):349-62. PubMed ID: 4187166
    [No Abstract]   [Full Text] [Related]  

  • 22. Gilbert's syndrome--does it exist? A study of the prevalence of symptoms in Gilbert's syndrome.
    Olsson R; Bliding A; Jagenburg R; Lapidus L; Larsson B; Svärdsudd K; Wittboldt S
    Acta Med Scand; 1988; 224(5):485-90. PubMed ID: 3264448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation between vascular and metabolic effects of nicotinic acid in Gilbert's syndrome.
    Gentile S; Marmo R; Persico M; Faccenda F; Orlando C; Rubba P
    Clin Physiol; 1990 Mar; 10(2):171-8. PubMed ID: 2318027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mild haemolytic condition observed in gilbert's cholemia: a common unexplained haematologic disorder.
    Perona G; Cellerino R; Corrocher R; Pizzolo G; Cetto G
    Haematologica; 1976 Sep; 61(3):317-27. PubMed ID: 828125
    [No Abstract]   [Full Text] [Related]  

  • 26. Nicotinic acid test in the diagnosis of Gilbert's syndrome: correlation with bilirubin clearance.
    Röllinghoff W; Paumgartner G; Preisig R
    Gut; 1981 Aug; 22(8):663-8. PubMed ID: 7286783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Latent porphyria cutanea tarda].
    Krivosheev BN
    Vestn Dermatol Venerol; 1989; (4):64-8. PubMed ID: 2763712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT).
    Dabrowska E; Jabłońska-Kaszewska I; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():282-6. PubMed ID: 12211737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of phenobarbital on unconjugated bilirubin clearance, gamma-glutamyltranspeptidase and urinary d-glucaric acid in patients with Gilbert's syndrome.
    Kawasaki H; Murawaki Y; Kimura N; Hirayama C
    Hepatogastroenterology; 1982 Dec; 29(6):252-5. PubMed ID: 6130037
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bright yellow--the extended spectrum of Gilbert's syndrome.
    June CH; Benjamin SB
    Am J Gastroenterol; 1984 Jun; 79(6):482-4. PubMed ID: 6731424
    [No Abstract]   [Full Text] [Related]  

  • 32. A modeling study of the effect of fasting on bilirubin kinetics in Gilbert's syndrome.
    Okolicsanyi L; Orlando R; Venuti M; Dal Brun G; Cobelli C; Ruggeri A; Salvan A
    Am J Physiol; 1981 May; 240(5):R266-71. PubMed ID: 7235043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeine clearance in subjects with constitutional unconjugated hyperbilirubinemia.
    Testa R; Bardellini E; Borzone S; Montani P; Risso D; Bindi P; Caglieris S; Campo N; Alvarez S; Pireddu M
    Ital J Gastroenterol; 1995 Apr; 27(3):129-32. PubMed ID: 7548921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Summary of experiences with the nicotinic acid and low-calorie tests in Gilbert's syndrome].
    Kupczyk K
    Pol Tyg Lek; 1981; 36(42-52):1627-9. PubMed ID: 7345409
    [No Abstract]   [Full Text] [Related]  

  • 35. Porphyria cutanea tarda, hepatitis C virus and selected symptoms of cholestasis.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Podlaska M; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():185-9. PubMed ID: 12211717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromsulfophthalein clearance and aminopyrine test in patients with Gilbert's syndrome.
    Bar-Meir S; Bar-Tal L; Papa MZ; Peled Y
    Isr J Med Sci; 1986 May; 22(5):376-9. PubMed ID: 3744786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The nicotinic acid and rifampicin tests in Gilbert's syndrome].
    Pérez Blanco FJ; Martín Ruíz JL; Caballero Plasencia A; González Calvín J; Montero García M; Peña Angulo JF
    Rev Esp Enferm Apar Dig; 1985 Aug; 68(2):127-30. PubMed ID: 4070734
    [No Abstract]   [Full Text] [Related]  

  • 38. [Kinetics of the disappearance of bilirubin in Gilbert's syndrome. Further case studies].
    Biagi P
    Quad Sclavo Diagn; 1981 Mar; 17(1):54-60. PubMed ID: 7313070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum bile acids in Gilbert's syndrome after oral load of chenodeoxycholic acid.
    Foberg U; Frydén A; Kågedal B; Tobiasson P
    Scand J Gastroenterol; 1985 Apr; 20(3):325-9. PubMed ID: 4001842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma sulfobromophthalein disappearance in Gilbert's syndrome.
    Serra MA; Aparisi L; García F; Del Olmo JA; Gilabert MS; Rodríguez F; Escudero A; Wassel A; Rodrigo JM
    Hepatogastroenterology; 1997; 44(13):210-4. PubMed ID: 9058146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.